AMD |
Age-related macular degeneration |
nvAMD |
Neovascular age-related macular degeneration |
CNV |
Choroidal neovascularization |
BrM |
Bruch’s Membrane |
GA |
Geographic atrophy |
OS |
Outer photoreceptor segments |
RPE |
Retinal pigment epithelium |
MHC |
Major histocompatibility complex |
IL |
Interleukin |
A2E |
N-Retinylidene-N-Retinylethanolamine |
PUFA |
Polyunsaturated fatty acids |
ROS |
Reactive oxygen species |
VEGF |
Vascular endothelial growth factor |
PIGF |
Placental growth factor |
VEGFR |
Vascular endothelial growth factor receptor |
Th2 |
Helper T-cells type 1 |
Th2 |
Helper T-cells type 2 |
Tie2 |
Tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 2 |
Ang |
Angiopoietin |
PDT |
Photodynamic therapy |
SNRVM |
Sub-retinal neovascular membrane |
Anti-VEGF |
Anti-vascular endothelial growth factor |
AAV |
Aden-associated virus |
Rock |
Rho-associated protein kinase |
OR |
Odds ratio |
HR |
Hazard ratio |